Square Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SQUARE PHARMS, and what generic and branded alternatives to SQUARE PHARMS drugs are available?
SQUARE PHARMS has five approved drugs.
Summary for Square Pharms
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Square Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Square Pharms | VALSARTAN | valsartan | TABLET;ORAL | 205347-004 | Apr 9, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Square Pharms | ARIPIPRAZOLE | aripiprazole | TABLET, ORALLY DISINTEGRATING;ORAL | 090165-003 | Aug 28, 2018 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Square Pharms | VALSARTAN | valsartan | TABLET;ORAL | 205347-003 | Apr 9, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Square Pharms | ARIPIPRAZOLE | aripiprazole | TABLET, ORALLY DISINTEGRATING;ORAL | 090165-004 | Aug 28, 2018 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Square Pharms | CALCIUM ACETATE | calcium acetate | CAPSULE;ORAL | 217205-001 | Mar 13, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
